The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S,E)-N-(3-ethyl-1H-indol-1-yl)-7-methoxytetradec-4-enamide ID: ALA2298969
PubChem CID: 76313369
Max Phase: Preclinical
Molecular Formula: C25H38N2O2
Molecular Weight: 398.59
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCC[C@@H](C/C=C/CCC(=O)Nn1cc(CC)c2ccccc21)OC
Standard InChI: InChI=1S/C25H38N2O2/c1-4-6-7-8-10-15-22(29-3)16-11-9-12-19-25(28)26-27-20-21(5-2)23-17-13-14-18-24(23)27/h9,11,13-14,17-18,20,22H,4-8,10,12,15-16,19H2,1-3H3,(H,26,28)/b11-9+/t22-/m0/s1
Standard InChI Key: WHHZXEJMALIVOZ-CRWWQRIJSA-N
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
14.5402 -6.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2479 -6.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9556 -6.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6634 -6.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3711 -6.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0788 -6.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7865 -6.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4942 -6.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2019 -6.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4942 -5.6172 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2019 -5.2086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9096 -6.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6173 -6.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3250 -6.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0327 -6.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7404 -6.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4481 -6.8429 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.7404 -5.6172 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.4481 -7.6601 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8618 -8.9196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1142 -8.1424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0445 -8.9196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7934 -8.1433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9972 -7.9739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4512 -8.5800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7070 -9.3581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5027 -9.5238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3422 -9.5807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1549 -9.4952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 1 6
10 11 1 0
9 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 23 1 0
22 20 1 0
20 21 2 0
21 19 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
20 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.59Molecular Weight (Monoisotopic): 398.2933AlogP: 6.38#Rotatable Bonds: 14Polar Surface Area: 43.26Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.29CX Basic pKa: ┄CX LogP: 6.26CX LogD: 6.26Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.30Np Likeness Score: 0.58
References 1. Reddy GV, Kumar TV, Siva B, Babu KS, Srinivas PV, Sehar I, Saxena AK, Rao JM. (2013) Novel malyngamide structural analogs: synthesis and biological evaluation, 22 (10): [10.1007/s00044-013-0466-y ]